Teva- Pharmaceutical Industries (TEVA)

Company Profile

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.

Company profile

Ticker

TEVA

Exchange

NYSE

Website

www.tevapharm.com

CEO

Kaare Schultz

Incorporated

Israel

Location

Israel

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies • Celgene ...

Former names

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

SEC CIK

0000818686

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Actavis Group • Actavis International Limited • Actavis U.K. Group Ltd. • Mepha Schweiz AG • Merckle GmbH • Norton Healthcare Ltd. • Norton (Waterford) Ltd. • Pliva Hrvatska d.o.o. • Ratiopharm GmbH • Teva API B.V. ...

TEVA stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$10.50

Low target

$10.00

High target

$11.00

Latest filings (excl ownership)

View all

8-K

Teva Concludes Nationwide Opioids Settlement Agreement

8 Jun 23

DEFA14A

Additional proxy soliciting materials

24 May 23

Conflict minerals disclosure

24 May 23

8-K

Departure of Directors or Certain Officers

10 May 23

Results of Operations and Financial Condition

10 May 23

ARS

2022 FY

Annual report to shareholders

19 Apr 23

DEFA14A

Additional proxy soliciting materials

Entry into a Material Definitive Agreement

9 Mar 23

Transcripts

View all

TEVA

Earnings call transcript

2023 Q1

10 May 23

TEVA

Earnings call transcript

2022 Q4

8 Feb 23

TEVA

Earnings call transcript

2022 Q2

27 Jul 22

TEVA

Earnings call transcript

2022 Q2

27 Jul 22

TEVA

Earnings call transcript

2022 Q1

3 May 22

TEVA

Earnings call transcript

2021 Q4

9 Feb 22

TEVA

Earnings call transcript

2021 Q3

27 Oct 21

TEVA

Earnings call transcript

2021 Q2

28 Jul 21

TEVA

Earnings call transcript

2021 Q1

28 Apr 21

TEVA

Earnings call transcript

2021 Q1

28 Apr 21

Latest ownership filings

View all

SC 13G/A

Capital Research Global Investors

Financial summary

Financial statements Chart TEVA financial data

Quarter (USD)	Mar 23	Dec 22	Sep 22	Jun 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.18 bn	2.18 bn	2.18 bn	2.18 bn	2.18 bn	2.18 bn
Cash burn (monthly)	219.33 mm	6.17 mm	(no burn)	115.25 mm	48.33 mm	(no burn)
Cash used (since last report)	513.89 mm	14.45 mm	n/a	270.03 mm	113.24 mm	n/a
Cash remaining	1.66 bn	2.16 bn	n/a	1.91 bn	2.06 bn	n/a
Runway (months of cash)	7.6	350.5	n/a	16.5	42.7	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q1 2023

TEVA institutional ownership history Ownership history

57.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	420	418	+0.5%
Opened positions	53	50	+6.0%
Closed positions	51	58	-12.1%
Increased positions	114	125	-8.8%
Reduced positions	141	139	+1.4%

13F shares	Current	Prev Q	Change
Total value	4.87 tn	4.76 tn	+2.3%
Total shares	642.94 mm	653.42 mm	-1.6%
Total puts	23.41 mm	27.60 mm	-15.2%
Total calls	21.76 mm	24.92 mm	-12.7%
Total put/call ratio	1.1	1.1	-2.9%

Largest owners	Shares	Value	Change
Capital Research Global Investors	82.64 mm	$731.40 bn	-28.0%
Europacific Growth Fund	52.75 mm	$813.41 mm	0.0%
Capital World Investors	50.64 mm	$448.16 bn	+0.1%
BLK Blackrock	40.17 mm	$355.47 bn	-0.5%
Allergan	39.62 mm	$763.43 mm	0.0%
Ion Asset Management	28.19 mm	$249.47 bn	+442.4%
Menora Mivtachim	26.64 mm	$235.77 bn	+14.5%
Migdal Insurance & Financial	23.35 mm	$206.60 bn	+8.1%
Harel Insurance Investments & Financial Services	23.30 mm	$206.17 bn	+54.1%
PXGPE Phoenix	22.13 mm	$195.88 bn	-0.1%

Largest transactions	Shares	Bought/sold	Change
Capital Research Global Investors	82.64 mm	-32.15 mm	-28.0%
Ion Asset Management	28.19 mm	+22.99 mm	+442.4%
Harel Insurance Investments & Financial Services	23.30 mm	+8.18 mm	+54.1%
Abrams Capital Management	7.97 mm	-7.97 mm	-50.0%
Citadel Advisors	9.55 mm	+6.88 mm	+257.5%
LGEN Legal & General	3.36 mm	-6.33 mm	-65.3%
BSN Capital Partners	0.00	-6.00 mm	EXIT
Rubric Capital Management	4.50 mm	+4.50 mm	NEW
STT State Street	19.56 mm	+4.44 mm	+29.4%
Two Sigma Investments	1.15 mm	-4.41 mm	-79.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TEVA insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
7 Mar 23	Richard Daniell	Ordinary Shares	Sell	Dispose S	No	Yes	9.4279	54,007	509.17 k	69,770
7 Mar 23	Sven Dethlefs	Ordinary Shares	Sell	Dispose S	No	Yes	9.4279	58,066	547.44 k	165,381
7 Mar 23	Eric Drape	Ordinary Shares	Sell	Dispose S	No	Yes	9.4279	4,699	44.30 k	173,262
7 Mar 23	David Matthew Stark	Ordinary Shares	Sell	Dispose S	No	Yes	9.4279	49,475	466.45 k	2,974.39
6 Mar 23	Richard Daniell	Ordinary Shares	Sell	Dispose S	No	Yes	9.9309	18,002	178.78 k	123,777
6 Mar 23	Sven Dethlefs	Ordinary Shares	Sell	Dispose S	No	Yes	9.9309	19,355	192.21 k	223,447
6 Mar 23	Eric Drape	Ordinary Shares	Sell	Dispose S	No	Yes	9.9309	1,566	15.55 k	177,961
6 Mar 23	David Matthew Stark	Ordinary Shares	Sell	Dispose S	No	Yes	9.9309	16,491	163.77 k	52,449.39
5 Mar 23	Richard Daniell	Ordinary Shares	Option exercise	Acquire M	No	No	0	22,576	0.00	141,779
5 Mar 23	Richard Daniell	Restricted Share Units Ordinary Shares	Option exercise	Dispose M	No	No	0	22,576	0.00	45,152